MDCX vs SNY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 05, 2026

MDCX

50.8
AI Score
VS
MDCX Wins

SNY

39.5
AI Score

Investment Advisor Scores

MDCX

51score
Recommendation
HOLD

SNY

40score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric MDCX SNY Winner
Forward P/E 0 8.5911 Tie
PEG Ratio 0 28.6272 Tie
Revenue Growth 0.0% 14.6% SNY
Earnings Growth 0.0% -91.2% MDCX
Tradestie Score 50.8/100 39.5/100 MDCX
Profit Margin 0.0% 8.1% SNY
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY MDCX

Relative Price Performance (Last 90 Days)

MDCX 1M: -0.5% · 3M: -61.5% SNY 1M: -11.2% · 3M: -8.4%

Current Technical Phase

MDCX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -29.7%), weak momentum, RSI 40

RSI (14): 40.4 · Price: $0.17

SNY

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.4%), weak momentum, RSI 26

RSI (14): 26.1 · Price: $39.38

Fundamentals Snapshot

Metric MDCX SNY
Market Cap — —
Forward P/E -0.6 7.4
Trailing P/E — 22.2
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin — 0.7%
Operating Margin 0.0% 0.2%
EPS -2.33 1.83
Dividend Yield — 0.10%

Frequently Asked Questions

Based on our detailed analysis, MDCX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.